Delcath Systems Share Price Today
(NASDAQ: DCTH)

Name: Delcath Systems Share Price Today (NASDAQ: DCTH) - Delcath Systems Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Delcath Systems share price is $13.43 & ₹1,167.99 as on 6 Mar 2025, 2.30 'hrs' IST

$13.43

▲

-0.34

(-2.47%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Delcath Systems share price in Dollar and Rupees. Guide to invest in Delcath Systems stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Delcath Systems, along with analyst recommendations, forecasts, and comprehensive financials.

Delcath Systems share price movements

Today's Low: $13.28
Today's High: $14.03
$13.43
1.12%
Downside
Day's Volatility :5.31%
Upside
4.24%
52 Weeks Low: $3.70
52 Weeks High: $16.97
$13.43
72.45%
Downside
52 Weeks Volatility :78.2%
Upside
20.86%

Delcath Systems (DCTH) Returns

Period	Delcath Systems Inc	Index (Russel 2000)
3 Months	19.95%	0.0%
6 Months	31.77%	0.0%
1 Year	253.08%	0.0%
3 Years	122.82%	-11.6%

Delcath Systems (DCTH) Key Statistics

in dollars & INR

Previous Close	$13.77
Open	$13.77
Today's High	$14.025
Today's Low	$13.28
Market Capitalization	$483.3M
Today's Volume	$94.4K
52 Week High	$16.97
52 Week Low	$3.7
Revenue TTM	$22.6M
EBITDA	$-26.6M
Earnings Per Share (EPS)	$-1.17
Profit Margin	-150.7%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-174.71%

How to invest in Delcath Systems Stock (DCTH) from India?

It is very easy for Indian residents to invest directly in Delcath Systems from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Delcath Systems stock in both Indian Rupees (INR) and US Dollars (USD). Search for Delcath Systems or DCTH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Delcath Systems or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Delcath Systems shares which would translate to 0.065 fractional shares of Delcath Systems as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Delcath Systems, in just a few clicks!

Returns in Delcath Systems (DCTH) for Indian investors in Rupees

The Delcath Systems stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Delcath Systems investment value today

Current value as on today

₹3,49,322

Returns

₹2,49,322

(+249.32%)

Returns from Delcath Systems Stock

₹2,44,359 (+244.36%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Delcath Systems (DCTH)

-12%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Delcath Systems Stock from India on INDmoney has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Delcath Systems

Rosalind Advisors, Inc.
7.32%
Vivo Capital, LLC
4.72%
AIGH Capital Management, LLC
3.83%
Vanguard Group Inc
3.38%
Soleus Capital Management, L.P.
2.21%
Gilder Gagnon Howe & CO LLC
1.69%

Analyst Recommendation on Delcath Systems

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Delcath Systems(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Delcath Systems Stock (DCTH)

What analysts predicted

Upside of 62.57%

Target:

$21.83

Current:

$13.43

Insights on Delcath Systems Stock (Ticker Symbol: DCTH)

Price Movement
In the last 3 months, DCTH stock has moved up by 19.9%
Increasing Revenue
Revenue is up for the last 5 quarters, 434.0K → 9.56M (in $), with an average increase of 45.2% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -13.74M → 1.86M (in $), with an average increase of 837.2% per quarter
DCTH vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 135.7% return, outperforming this stock by 10.7%

DCTH Delcath Systems Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$3.4M	↑ 25.49%
Net Income	$-19.2M	↓ 57.4%
Net Profit Margin	-564.19%	↑ 1097.58%

	FY19	Y/Y Change
Revenue	$1.6M	↓ 53.62%
Net Income	$-13.6M	↓ 29.11%
Net Profit Margin	-862.47%	↓ 298.28%

	FY20	Y/Y Change
Revenue	$1.6M	↑ 4.18%
Net Income	$-24.5M	↑ 79.68%
Net Profit Margin	-1.5K%	↓ 625.08%

	FY21	Y/Y Change
Revenue	$3.6M	↑ 115.98%
Net Income	$-26.8M	↑ 9.28%
Net Profit Margin	-752.66%	↑ 734.89%

	FY22	Y/Y Change
Revenue	$2.7M	↓ 23.52%
Net Income	$-39.2M	↑ 46.37%
Net Profit Margin	-1.4K%	↓ 687.69%

	FY23	Y/Y Change
Revenue	$2.1M	↓ 24.05%
Net Income	$-47.7M	↑ 21.74%
Net Profit Margin	-2.3K%	↓ 868.51%

	Q2 FY23	Q/Q Change
Revenue	$495.0K	↓ 17.09%
Net Income	$-7.2M	↓ 30.5%
Net Profit Margin	-1.5K%	↑ 280.9%

	Q3 FY23	Q/Q Change
Revenue	$434.0K	↓ 12.32%
Net Income	$-20.3M	↑ 182.42%
Net Profit Margin	-4.7K%	↓ 3231.69%

	Q4 FY23	Q/Q Change
Revenue	$539.0K	↑ 24.19%
Net Income	$-11.1M	↓ 45.25%
Net Profit Margin	-2.1K%	↑ 2620.59%

	Q1 FY24	Q/Q Change
Revenue	$3.1M	↑ 482.37%
Net Income	$-11.1M	↓ 0.22%
Net Profit Margin	-353.97%	↑ 1712.08%

	Q2 FY24	Q/Q Change
Revenue	$7.8M	↑ 147.4%
Net Income	$-13.7M	↑ 23.67%
Net Profit Margin	-176.94%	↑ 177.03%

	Q3 FY24	Q/Q Change
Revenue	$9.6M	↑ 23.1%
Net Income	$1.9M	↓ 113.57%
Net Profit Margin	19.5%	↑ 196.44%

	FY18	Y/Y Change
Profit	$2.4M	↑ 19.07%

	FY19	Y/Y Change
Profit	$861.0K	↓ 64.1%

	FY20	Y/Y Change
Profit	$1.0M	↑ 16.84%

	FY21	Y/Y Change
Profit	$2.9M	↑ 186.68%

	FY22	Y/Y Change
Profit	$2.0M	↓ 29.51%

	FY23	Y/Y Change
Profit	$1.4M	↓ 29.66%

	Q2 FY23	Q/Q Change
Profit	$345.0K	↓ 17.07%

	Q3 FY23	Q/Q Change
Profit	$301.0K	↓ 12.75%

	Q4 FY23	Q/Q Change
Profit	$327.0K	↑ 8.64%

	Q1 FY24	Q/Q Change
Profit	$2.2M	↑ 583.79%

	Q2 FY24	Q/Q Change
Profit	$6.2M	↑ 179.38%

	Q3 FY24	Q/Q Change
Profit	$9.6M	↑ 53.03%

	FY18	Y/Y Change
Operating Cash Flow	$-14.7M	↓ 4.33%
Investing Cash Flow	$-76.0K	↓ 85.5%
Financing Cash Flow	$13.2M	↓ 14.3%

	FY19	Y/Y Change
Operating Cash Flow	$-23.7M	↑ 60.81%
Investing Cash Flow	$-24.0K	↓ 68.42%
Financing Cash Flow	$30.3M	↑ 128.96%

	FY20	Y/Y Change
Operating Cash Flow	$-22.9M	↓ 3.47%
Investing Cash Flow	$-782.0K	↑ 3158.33%
Financing Cash Flow	$42.4M	↑ 39.76%

	FY21	Y/Y Change
Operating Cash Flow	$-22.6M	↓ 1.15%
Investing Cash Flow	$-143.0K	↓ 81.71%
Financing Cash Flow	$20.8M	↓ 50.84%

	FY22	Y/Y Change
Operating Cash Flow	$-25.0M	↑ 10.38%
Investing Cash Flow	$-209.0K	↑ 46.15%
Financing Cash Flow	$10.1M	↓ 51.29%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-9.6M	↑ 126.27%
Investing Cash Flow	$-40.0K	↑ 0.0%
Financing Cash Flow	$7.0K	↓ 99.96%

Delcath Systems Technicals Summary

Sell

Neutral

Buy

Delcath Systems is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Delcath Systems (DCTH) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Delcath Systems Inc	-15.26%	31.77%	253.08%	122.82%	79.77%
Medtronic Plc	2.26%	4.07%	8.74%	-12.76%	0.68%
Edwards Lifesciences Corp.	0.07%	8.12%	-19.19%	-34.12%	12.08%
Boston Scientific Corp.	0.07%	27.33%	53.68%	143.5%	203.93%
Stryker Corporation	-0.63%	8.92%	9.84%	53.87%	125.87%
Abbott Laboratories	7.11%	21.64%	15.28%	15.75%	78.63%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Delcath Systems Inc	NA	NA	NA	-0.73	-1.75	-0.42	NA	0.31
Medtronic Plc	28.75	28.75	1.87	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	30.5	30.5	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	83.9	83.9	1.85	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.89	50.89	2.85	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Delcath Systems Inc	Buy	$483.3M	79.77%	NA	-150.7%
Medtronic Plc	Buy	$120.9B	0.68%	28.75	12.83%
Edwards Lifesciences Corp.	Buy	$42.0B	12.08%	30.5	76.75%
Boston Scientific Corp.	Buy	$154.8B	203.93%	83.9	11.07%
Stryker Corporation	Buy	$150.7B	125.87%	50.89	13.25%
Abbott Laboratories	Buy	$238.6B	78.63%	18.34	31.95%

About Delcath Systems

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Organization	Delcath Systems
Employees	76
CEO	Mr. Gerard J. Michel MBA, MS
Industry	Medical Specialties

Management People of Delcath Systems

Name	Title
Mr. Gerard J. Michel MBA, MS	CEO & Director
Dr. Martha S. Rook Ph.D.	Chief Operating Officer
Mr. David Hoffman J.D.	General Counsel, Corporate Secretary & Chief Compliance Officer
Dr. Johnny John M.D.	Senior Vice President of Clinical Operations & Medical Affairs
Dr. Vojislav Vukovic M.D., M.Sc., Ph.D.	Chief Medical Officer

Important FAQs about investing in DCTH Stock from India :

What is Delcath Systems share price today?

Delcath Systems share price today stands at $13.43, Open: $13.77 ; Previous Close: $13.77 ; High: $14.03 ; Low: $13.28 ; 52 Week High: $16.97 ; 52 Week Low: $3.70.

The stock opens at $13.77, after a previous close of $13.77. The stock reached a daily high of $14.03 and a low of $13.28, with a 52-week high of $16.97 and a 52-week low of $3.70.

Can Indians buy Delcath Systems shares?

Yes, Indians can invest in the Delcath Systems (DCTH) from India.

With INDmoney, you can buy Delcath Systems at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Delcath Systems at zero transaction cost.

How can I buy Delcath Systems shares from India?

It is very easy to buy Delcath Systems from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Delcath Systems (DCTH) be purchased?

Yes, you can buy fractional shares of Delcath Systems with INDmoney app.

What are the documents required to start investing in Delcath Systems stocks?

To start investing in Delcath Systems, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.